My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 146

    1.

    The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo.

    Bogacka I, Xie H, Bray GA, Smith SR.

    Diabetes Care. 2004 Jul;27(7):1660-7.PMID: 15220243 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial.

    Coletta DK, Sriwijitkamol A, Wajcberg E, Tantiwong P, Li M, Prentki M, Madiraju M, Jenkinson CP, Cersosimo E, Musi N, Defronzo RA.

    Diabetologia. 2009 Apr;52(4):723-32. Epub 2009 Jan 24.PMID: 19169664 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo.

    Bogacka I, Xie H, Bray GA, Smith SR.

    Diabetes. 2005 May;54(5):1392-9.PMID: 15855325 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The effect of beta-adrenergic and peroxisome proliferator-activated receptor-gamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue.

    Bogacka I, Gettys TW, de Jonge L, Nguyen T, Smith JM, Xie H, Greenway F, Smith SR.

    Diabetes Care. 2007 May;30(5):1179-86. Epub 2007 Mar 10.PMID: 17351280 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.

    Orasanu G, Ziouzenkova O, Devchand PR, Nehra V, Hamdy O, Horton ES, Plutzky J.

    J Am Coll Cardiol. 2008 Sep 2;52(10):869-81. Epub 2008 Jul 2.PMID: 18755353 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial.

    Smith SR, De Jonge L, Volaufova J, Li Y, Xie H, Bray GA.

    Metabolism. 2005 Jan;54(1):24-32.PMID: 15562376 [PubMed - indexed for MEDLINE]Related articles

    7.

    The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.

    Werner C, Kamani CH, Gensch C, Böhm M, Laufs U.

    Diabetes. 2007 Oct;56(10):2609-15. Epub 2007 Jul 10.PMID: 17623816 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes.

    Cadoudal T, Blouin JM, Collinet M, Fouque F, Tan GD, Loizon E, Beale EG, Frayn KN, Karpe F, Vidal H, Benelli C, Forest C.

    Diabetologia. 2007 Mar;50(3):666-75. Epub 2007 Jan 23.PMID: 17242918 [PubMed - indexed for MEDLINE]Related articles

    9.

    High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.

    Hammarstedt A, Pihlajamäki J, Graham TE, Kainulainen S, Kahn BB, Laakso M, Smith U.

    J Intern Med. 2008 Apr;263(4):440-9.PMID: 18324929 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.

    Berthiaume M, Laplante M, Tchernof A, Deshaies Y.

    Int J Obes (Lond). 2007 Nov;31(11):1660-70. Epub 2007 Jun 19.PMID: 17579631 [PubMed - indexed for MEDLINE]Related articles

    11.

    Induction of fatty acid translocase/CD36, peroxisome proliferator-activated receptor-gamma2, leptin, uncoupling proteins 2 and 3, and tumor necrosis factor-alpha gene expression in human subcutaneous fat by lipid infusion.

    Nisoli E, Carruba MO, Tonello C, Macor C, Federspil G, Vettor R.

    Diabetes. 2000 Mar;49(3):319-24.PMID: 10868951 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Correction of protein kinase C activity and macrophage migration in peripheral nerve by pioglitazone, peroxisome proliferator activated-gamma-ligand, in insulin-deficient diabetic rats.

    Yamagishi S, Ogasawara S, Mizukami H, Yajima N, Wada R, Sugawara A, Yagihashi S.

    J Neurochem. 2008 Jan;104(2):491-9. Epub 2007 Nov 6.PMID: 17995925 [PubMed - indexed for MEDLINE]Related articles

    13.

    The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.

    Mazzucotelli A, Viguerie N, Tiraby C, Annicotte JS, Mairal A, Klimcakova E, Lepin E, Delmar P, Dejean S, Tavernier G, Lefort C, Hidalgo J, Pineau T, Fajas L, Clément K, Langin D.

    Diabetes. 2007 Oct;56(10):2467-75. Epub 2007 Jul 23.PMID: 17646210 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.

    Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, DeFronzo RA.

    Diabetologia. 2007 Aug;50(8):1723-31. Epub 2007 May 23.PMID: 17520238 [PubMed - indexed for MEDLINE]Related articles

    15.

    Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones.

    Suzuki A, Yasuno T, Kojo H, Hirosumi J, Mutoh S, Notsu Y.

    Jpn J Pharmacol. 2000 Oct;84(2):113-23.PMID: 11128033 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle.

    Lapsys NM, Kriketos AD, Lim-Fraser M, Poynten AM, Lowy A, Furler SM, Chisholm DJ, Cooney GJ.

    J Clin Endocrinol Metab. 2000 Nov;85(11):4293-7.PMID: 11095470 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Subcutaneous abdominal adipose tissue subcompartments: potential role in rosiglitazone effects.

    Walker GE, Marzullo P, Verti B, Guzzaloni G, Maestrini S, Zurleni F, Liuzzi A, Di Blasio AM.

    Obesity (Silver Spring). 2008 Sep;16(9):1983-91.PMID: 19186324 [PubMed - indexed for MEDLINE]Related articles

    18.

    Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat.

    Hallakou S, Doaré L, Foufelle F, Kergoat M, Guerre-Millo M, Berthault MF, Dugail I, Morin J, Auwerx J, Ferré P.

    Diabetes. 1997 Sep;46(9):1393-9.PMID: 9287037 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of pioglitazone on suppressor of cytokine signaling 3 expression: potential mechanisms for its effects on insulin sensitivity and adiponectin expression.

    Kanatani Y, Usui I, Ishizuka K, Bukhari A, Fujisaka S, Urakaze M, Haruta T, Kishimoto T, Naka T, Kobayashi M.

    Diabetes. 2007 Mar;56(3):795-803.PMID: 17327450 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Agonist of peroxisome proliferator-activated receptor gamma (PPAR-gamma): a new compound with potent gastroprotective and ulcer healing properties.

    Brzozowski T, Konturek PC, Pajdo R, Kwiecień SN, Konturek S, Targosz A, Burnat G, Cieszkowski J, Pawlik WW, Hahn EG.

    Inflammopharmacology. 2005;13(1-3):317-30.PMID: 16259750 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity